Company Profile
Roche Holding AG is a Switzerland-based healthcare company and the world's largest provider of in vitro diagnostics (IVD), headquartered in Basel, Switzerland. Founded in 1896 by Fritz Hoffmann-La Roche, the company operates as a publicly listed entity on the SIX Swiss Exchange (RO, ROP) and OTCQX (RHHBY) with approximately 100,000+ employees, serving global healthcare markets across 150+ countries through its Diagnostics and Pharmaceuticals divisions.
Core Products ＆ Technologies
In Vitro Diagnostics
• cobas® Analysers: Fully automated clinical chemistry and immunoassay systems for high-throughput core laboratory testing
• cobas® 6800/8800 Systems: Molecular diagnostics platforms for PCR-based infectious disease, oncology, and virology testing
• Elecsys® Immunoassays: Broad menu of immunoassay reagents for cardiac, oncology, endocrine, and infectious disease markers
Digital Pathology ＆ Tissue Diagnostics
• Navify® Digital Pathology: Cloud-based image management and AI analysis platform for pathology laboratories; integration with PathAI AISight IMS pending acquisition close
• Ventana® Tissue Diagnostics: Automated immunohistochemistry (IHC) and in situ hybridization (ISH) staining systems for cancer biomarker detection
• DISCOVERY Ultra: High-capacity IHC/ISH staining platform for companion diagnostic development
Point-of-Care ＆ Diabetes Care
• Accu-Chek® Diabetes Care: Blood glucose monitoring systems, insulin pumps, and digital diabetes management solutions
• CoaguChek® Systems: Point-of-care coagulation monitoring for anticoagulation therapy management
• SARS-CoV-2 Rapid Antigen Tests: Near-patient rapid diagnostic tests for infectious disease screening
Market Position ＆ Certifications
Roche holds a global leadership position in the in vitro diagnostics and digital pathology market, competing with Abbott Laboratories, Siemens Healthineers, and Danaher Corporation (Beckman Coulter). Key strengths include:
• 130 years of Swiss healthcare innovation heritage since founding
• Diagnostics scale: CHF 13.8 billion diagnostics sales in 2025; largest global IVD player by revenue
• Regulatory compliance: CE-IVDR certified, FDA QSR compliant, ISO 13485:2016, and registered across major global health authorities
• AI transformation: Definitive agreement to acquire PathAI (May 2026) for $750M upfront to integrate AI-driven digital pathology and companion diagnostic algorithms
• Integrated healthcare: Unique combination of pharmaceuticals and diagnostics under one roof, enabling personalized medicine
Corporate Timeline
1896 — Founded in Basel, Switzerland, by Fritz Hoffmann-La Roche as a pharmaceutical company
1968 — Entered diagnostics market, establishing foundation for Roche Diagnostics
2000 — Acquired Genentech, strengthening biotech and oncology capabilities
2008 — Acquired Ventana Medical Systems, expanding tissue-based cancer diagnostics
2021 — Established strategic partnership with PathAI for AI-enabled pathology
2024 — Expanded PathAI partnership to include AI companion diagnostic algorithm development
2026 — Announced definitive agreement to acquire PathAI for up to $1.05 billion (May 7); Diagnostics Day event in London to outline digital pathology strategy
Target Markets ＆ Applications
• Core Laboratory: cobas analysers and Elecsys reagents for high-volume clinical chemistry, immunoassay, and molecular testing in hospital and reference labs
• Digital Pathology: Navify platform and Ventana IHC/ISH systems for cancer biomarker detection and AI-assisted diagnostic workflows
• Point-of-Care Testing: CoaguChek and rapid antigen tests for emergency, primary care, and home-use settings
• Diabetes Management: Accu-Chek portfolio for blood glucose monitoring and insulin delivery in Type 1 and Type 2 diabetes
• Companion Diagnostics: IHC/ISH-based CDx assays for oncology targeted therapies, including PD-L1, HER2, and ALK testing
Contact Information
Global Headquarters
Address: Grenzacherstrasse 124, 4053 Basel, Switzerland
Telephone: +41 61 688 11 11
Fax: +41 61 691 93 91
Corporate Status
Entity Type: Publicly Listed Company (No Parent Company)
Stock: SIX: RO, ROP / OTCQX: RHHBY
Website: roche.com
Investor Relations: roche.com/investors
